Clinical Practice Points
acute myeloid leukemia
ACUTE MYELOID LEUKEMIA

Adoptive transfer of γδ T lymphocytes from haploidentical donors in patients with refractory/relapsed acute myeloid leukemia was shown to be feasible and safe in a phase I trial.Further research on γδ T lymphocyte immunotherapy is warranted.